Abstract:Ginsenoside Re (1) and Notoginsenoside R-1 (2) are two representative dammarane type protopanaxatriol-6,20-O-bisglycosides occurring widely founded in Panaxginseng. Ginsenoside Re (1) showed potent antioxidative, anti-inflammatory and antihy perlipemia activities, and Notoginsenoside R-1 (2) showed potent antioxidative and antiinflammatory activities, so it would be helpful to synthesize these homogeneous natural products in appreciable amounts by accelerating their structure-activity relationship study. As a persistent effort on the chemical syntheses of the diverse ginsenosides in our group, we report herein the efficient syntheses of these two complex natural products. Thus, based on the reactivity sequence of the four hydroxyl groups (i.e., 12-OH> 3-OH>6-OH >> 20-OH) of the protopanaxatriol aglycon, an orthogonal and efficient protecting group strategy was applied to distinguish these hydroxyl groups. The subsequent installation of the 6,20-O-bisglycosides are challenging, given the poor reactivity of the secondary 6-OH and tertiary 20-OH, moreover, with the latter being labile toward acidic conditions. Taking advantage of the neutral conditions of the Au(I)-catalyzed glycosylation reaction (0.3 equiv. Ph3PAuNTf2, 4 angstrom MS, CH2Cl2, r.t.), the glycosylation of the acid-labile 20-hydroxyl group was achieved effectively in a high 84% yield firstly. To be convergent for the syntheses of these two ginsenosides, the 6-O-disorcharide residues were installed in a stepwise manner. For the glycosylation of the 6-OH of protopanaxatriol, a higher loading of the catalyst Ph3PAuNTf2 (0.5 equiv.) was employed in order to increase the glycosylation yield while reduce the orthoester formation, thus, the desired 6 beta-O-glucosides were prepared in satisfactory yields (77%similar to 83%). Both terminal alpha-L-Rha/beta-D-Xyl moieties at the 2' position of 6-O-glc were installed efficiently under 0.2 equiv. Ph-3 PAuNTf2 catalyzing condition (ClCH2CH2Cl, 5 angstrom MS, 40 degrees C) with 86% and 81% yields, respectively. After global deprotection, Ginsenoside Re (1) and Notoginsenoside R-1 (2) were synthesized with the longest 13 linear steps in 5.1% and 4.5% overall yields, respectively.

Total Synthesis and Cytotoxicity Evaluation of Spirostanol Saponin Gitonin

Synthesis of the Cytotoxic Gitogenin 3Β-O-[2-o-(α-l-rhamnopyranosyl)-β-d-galactopyranoside] and Its Congeners

Separation and Bio-Activities of Spirostanol Saponin from Tribulus Terrestris

Synthesis and Biological Evaluation of Novel Spin Labeled 18Β-Glycyrrhetinic Acid Derivatives

Synthesis of Novel Diosgenyl Saponin Analogs and Evaluation Effects of Rhamnose Moeity on Their Cytotoxic Activity.

Synthesis and Cytotoxic Activity of the N-acetylglucosamine-bearing Triterpenoid Saponins.

Novel Chemical Synthesis of Ginkgolic Acid (13:0) and Evaluation of Its Tyrosinase Inhibitory Activity

One-Pot Bi-Enzymatic Cascade Synthesis of Novel Ganoderma Triterpenoid Saponins

Spirostanol Sapogenins and Saponins from Convallaria majalis L. Structural Characterization by 2D NMR, Theoretical GIAO DFT Calculations and Molecular Modeling

Facile synthesis of four natural triterpene saponins with important antitumor activity

Semisynthesis and bioactive evaluation of oxidized products from 20(S)-ginsenoside Rg3, Rh2, protopanaxadiol (PPD) and their 20(R)-epimers as cytotoxic agents

Synthesis and Biological Evaluation of a Natural Ester Sintenin and Its Synthetic Analogues

New Apiose-Containing Triterpenoid Saponins from Conyza Blinii

Convergent synthesis of glycoalkaloids solasonine and its saponin derivative

Highly Efficient Synthesis of Bioactive Oleanane-Type Saponins.

Novel Ganoderma triterpenoid saponins from the biotransformation-guided purification of a commercial Ganoderma extract

Synthesis and Cytotoxic Property of Annonaceous Acetogenin Glycoconjugates

Syntheses of Chlorogenin 6Α-O-acyl-3-o-β-chacotriosides and Their Antitumor Activities

Total Synthesis of Dammarane-Type Saponins Ginsenoside Re and Notoginsenoside R1

Total synthesis of starfish saponin goniopectenoside B

20-esterification of 5-spiro CPT and their anticancer activity in vitro